HMN and PM360 Hold 1st Annual DTP Conference


On September 18th, Health Monitor Network and PM360 joined together to host the 1st Annual DTP Conference. Held in New York City, this exclusive product manager-only event was attended by representatives from pharma’s leading companies, including Merck, Eli Lilly, Celgene, Novo Nordisk, AstraZeneca, Pfizer, Entera Health, GlaxoSmithKline, Nicox and more.

This unique conference was created in response to the changing dynamics of the healthcare marketplace and to answer the pressing questions that pharma marketers are voicing across all therapeutic categories. Speakers and panelists included patients, healthcare professionals, patient advocacy associations/groups, health-system executives, patient-level data research experts, seasoned brand managers and pharma consultants.

Following a warm welcome from Ken Freirich, Health Monitor Network’s President, the conference began with an energetic presentation by Stan Bernard, MD, President of Bernard Associates, on how to “win with patients” in Pharma 2.0. The morning also featured patient-level data experts and a panel of HCPs who shared their perspective on the evolving role of DTP in daily practice.

The afternoon continued with sessions on the importance of patient advocacy organizations, patients’ perspectives on DTP, healthcare social media, the changing landscape of care delivery through health systems and a panel on product manager best DTP practices. The conference’s interactive Q&A format allowed for open dialogue between the audience and speakers, making the day a highly informative and educational event.


You May Also Like

The Moment Is The Medium: Marketing In A Post-Digital Age

The last two decades of digital media innovation have created fundamental shifts in our ...

Healthcare Watch April 2021

Patient Pages: Data Privacy from Patient Perspective Now that many of today’s innovations are ...

Marketing to Millennials: New Clues to Connecting with the “Worried Well”

How do you market conventional healthcare solutions to a self-diagnosing generation that wants a ...